Susquehanna International Group
SRRA

Susquehanna International Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

Susquehanna International Group’s Portfolio SRRA Stock Details SRRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-66,400
Closed -$3.48M – 14493
2022
Q1 		$2.13M Buy
+66,400
New +$1.91M ﹤0.01% 5341
2019
Q4 		– Sell
-674
Closed -$11K – 10993
2019
Q3 		$11K Buy
+674
New +$12.9K ﹤0.01% 10015
2019
Q1 		– Sell
-371
Closed -$20K – 10188
2018
Q4 		$20K Buy
+371
New +$23.7K ﹤0.01% 8681
2017
Q4 		– Sell
-1,371
Closed -$85K – 10136
2017
Q3 		$85K Sell
1,371
-11,407
-89% -$669K ﹤0.01% 8416
2017
Q2 		$598K Sell
12,778
-897
-7% -$45.8K ﹤0.01% 6302
2017
Q1 		$837K Buy
13,675
+13,233
+2,994% +$769K ﹤0.01% 5510
2016
Q4 		$26K Sell
442
-156
-26% -$9.72K ﹤0.01% 9398
2016
Q3 		$44K Buy
+598
New +$46.2K ﹤0.01% 8162
2016
Q2 		– Sell
-1,504
Closed -$405K – 9569
2016
Q1 		$405K Buy
1,504
+1,144
+318% +$365K ﹤0.01% 6766
2015
Q4 		$216K Buy
+360
New +$244K ﹤0.01% 8295

Other funds holding SRRA

HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return

Susquehanna International Group's SRRA Position: Q2 2022 in Review

Susquehanna International Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q2 2022, closing a stake of 66,400 shares — an estimated $3.48M sold.

Susquehanna International Group first reported a position in SRRA in Q4 2015 and held it in 10 quarters. The position peaked at $2.13M in Q1 2022. 109 funds tracked by Wall St. Rank hold SRRA as of Q2 2022.

  • Susquehanna International Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Susquehanna International Group sold 66,400 Sierra Oncology, Inc. Common Stock shares in Q2 2022, an estimated $3.48M.
  • Susquehanna International Group first reported a position in Sierra Oncology, Inc. Common Stock in Q4 2015 and held it in 10 quarters.
  • Susquehanna International Group's Sierra Oncology, Inc. Common Stock position peaked at $2.13M in Q1 2022.
  • 109 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q2 2022.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.